SQZ BIOTECHNOLOGIES COMPANY Variable Lease, Cost
SQZ BIOTECHNOLOGIES COMPANY reported Variable Lease, Cost of $21.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2022-03-16
- SQZ BIOTECHNOLOGIES COMPANY variable lease, cost for the quarter ending 2020-12-31 was $0.00.
- SQZ BIOTECHNOLOGIES COMPANY variable lease, cost for the quarter ending 2020-09-30 was $306.00K, a 152.89% increase year-over-year.
- SQZ BIOTECHNOLOGIES COMPANY variable lease, cost for the quarter ending 2020-06-30 was $0.00.
- SQZ BIOTECHNOLOGIES COMPANY variable lease, cost for the quarter ending 2020-03-31 was $21.00K.
- SQZ BIOTECHNOLOGIES COMPANY variable lease, cost for fiscal 2020 was $21.00K, a 81.25% decline from fiscal 2019.
- SQZ BIOTECHNOLOGIES COMPANY variable lease, cost for fiscal 2019 was $112.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $306.00K derived: sum of 2 quarters · filed 2022-03-16 | $306.00K derived: sum of 3 quarters · filed 2022-03-16 | $21.00K 10-K · filed 2022-03-16 | |
| 2020-09-30 | $306.00K 10-Q · filed 2020-12-10 | $306.00K derived: sum of 2 quarters · filed 2021-08-04 | $21.00K 10-Q · filed 2021-11-10 | $908.00K 10-Q · filed 2020-12-10 | $56.00K derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $21.00K 10-Q · filed 2021-08-04 | -$250.00K derived: sum of 3 quarters · filed 2021-08-04 | -$129.00K derived: sum of 4 quarters · filed 2021-08-04 | |
| 2020-03-31 | $21.00K 10-Q · filed 2021-05-11 | -$250.00K derived: sum of 2 quarters · filed 2021-05-11 | -$129.00K derived: sum of 3 quarters · filed 2021-05-11 | ||
| 2019-12-31 | -$271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$150.00K derived: sum of 2 quarters · filed 2021-03-18 | $112.00K 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $121.00K 10-Q · filed 2020-12-10 | $383.00K 10-Q · filed 2020-12-10 |